BX-667

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBX-667
Drug Alias NameP2Y12 purinoceptor antagonist (Berlex)BX-048BX-667
ClassificationSmall molecules
Mechanisms of ActionPlatelet aggregation inhibitorsPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBerlex Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBerlex Biosciences Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A